Many clients with Parkinson's disease experience negative feelings about how they appear, because of the manifestations of this disease. An appropriate goal for these clients would be:
a. Client will experience decreasing tremors and spasms.
b. Client will verbalize positive feelings about body image.
c. Client will verbalize understanding of disease process and treatment plan.
d. Client will maintain weight within defined limits.
ANS: B
Feedback
A Incorrect: Although a possible goal for this problem, it is not the best goal.
B Correct: The manifestations frequently cause a disturbed body image and this is the best goal for this problem.
C Incorrect: This goal addresses Deficient knowledge.
D Incorrect: This goal addresses Imbalanced nutrition, less than body requirements.
You might also like to view...
The nurse is assessing a client's pupilary response. Which of the following is considered normal?
a. Right pupil larger than left and sluggish response to light b. Left pupil larger than right and sluggish response to light c. Pupils equal round and reactive to light and accommodation d. Bright red conjunctiva
Prior to beginning a blood transfusion, it is essential for the nurse to:
1. check the client's intake and output. 2. question the client about any allergies. 3. measure the client's vital signs, including temperature. 4. determine if the client has had any previous transfusions.
What is the expected client response to the presence of antidiuretic hormone (ADH) on urine output and osmolarity?
A. Increased urine output, increased urine osmolarity B. Increased urine output, decreased urine osmolarity C. Decreased urine output, increased urine osmolarity D. Decreased urine output, decreased urine osmolarity
Tuberculin purified protein derivative:
1. Is administered to patients who are known tuberculin-positive reactors 2. May be administered to patients who are on immunosuppressives 3. May be administered 2 to 3 weeks after an MMR or varicella vaccine 4. May be administered the same day as the MMR and/or varicella vaccine